ECSP12012100A - Composición de vacuna conjugada de polisacárido- proteína neumocócica 15-valente referencia cruzada a solicitudes relacionadas - Google Patents

Composición de vacuna conjugada de polisacárido- proteína neumocócica 15-valente referencia cruzada a solicitudes relacionadas

Info

Publication number
ECSP12012100A
ECSP12012100A ECSP12012100A ECSP12012100A EC SP12012100 A ECSP12012100 A EC SP12012100A EC SP12012100 A ECSP12012100 A EC SP12012100A EC SP12012100 A ECSP12012100 A EC SP12012100A
Authority
EC
Ecuador
Prior art keywords
protein
composition
polisacárido
pneumocócica
related applications
Prior art date
Application number
Other languages
English (en)
Spanish (es)
Inventor
Michael J Caulfield
Patrick L Ahl
Jeffrey T Blue
Jayme L Cannon
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of ECSP12012100A publication Critical patent/ECSP12012100A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ECSP12012100 2010-02-09 2012-08-09 Composición de vacuna conjugada de polisacárido- proteína neumocócica 15-valente referencia cruzada a solicitudes relacionadas ECSP12012100A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30272610P 2010-02-09 2010-02-09

Publications (1)

Publication Number Publication Date
ECSP12012100A true ECSP12012100A (es) 2013-03-28

Family

ID=44353903

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP12012100 ECSP12012100A (es) 2010-02-09 2012-08-09 Composición de vacuna conjugada de polisacárido- proteína neumocócica 15-valente referencia cruzada a solicitudes relacionadas

Country Status (25)

Country Link
US (2) US8192746B2 (fr)
EP (1) EP2533805A4 (fr)
JP (2) JP2013518891A (fr)
KR (1) KR101538535B1 (fr)
CN (1) CN102858365A (fr)
AR (2) AR080122A1 (fr)
AU (1) AU2011216095B2 (fr)
BR (1) BR112012019757B8 (fr)
CA (1) CA2788680C (fr)
CL (1) CL2012002195A1 (fr)
EC (1) ECSP12012100A (fr)
IL (1) IL221283A0 (fr)
MA (1) MA34051B1 (fr)
MX (1) MX2012009206A (fr)
MY (1) MY159984A (fr)
NZ (1) NZ601711A (fr)
PE (1) PE20121698A1 (fr)
PH (1) PH12012501559A1 (fr)
RU (1) RU2012138368A (fr)
SG (2) SG183199A1 (fr)
TN (1) TN2012000377A1 (fr)
TW (1) TW201136603A (fr)
UA (1) UA106115C2 (fr)
WO (1) WO2011100151A1 (fr)
ZA (1) ZA201205737B (fr)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3311836A1 (fr) 2005-04-08 2018-04-25 Wyeth LLC Composition conjuguée polysaccharide-protéine pneumococcique polyvalente
PE20110072A1 (es) * 2005-06-27 2011-02-04 Glaxosmithkline Biolog Sa Composicion inmunogenica
JP5814507B2 (ja) * 2006-09-07 2015-11-17 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
TWI815599B (zh) 2011-04-22 2023-09-11 美商惠氏有限責任公司 與難養芽胞梭菌（Ｃｌｏｓｔｒｉｄｉｕｍ ｄｉｆｆｉｃｉｌｅ）之突變毒素有關之組成物及彼之方法
IN2014CN03391A (fr) * 2011-11-23 2015-07-03 Merck Sharp & Dohme
KR102057217B1 (ko) 2012-06-20 2020-01-22 에스케이바이오사이언스 주식회사 다가 폐렴구균 다당류-단백질 접합체 조성물
US20140193451A1 (en) * 2012-10-17 2014-07-10 Glaxosmithkline Biologicals Sa Immunogenic composition
BR122016023101B1 (pt) 2012-10-21 2022-03-22 Pfizer Inc Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile
KR20140075201A (ko) * 2012-12-11 2014-06-19 에스케이케미칼주식회사 다가 폐렴구균 다당류-단백질 접합체 조성물
KR20140075196A (ko) 2012-12-11 2014-06-19 에스케이케미칼주식회사 다가 폐렴구균 다당류-단백질 접합체 조성물
CN103495161B (zh) * 2013-10-08 2019-06-18 江苏康泰生物医学技术有限公司 一种多元肺炎球菌荚膜多糖-蛋白质结合物的混合物及其制备方法
TWI586363B (zh) * 2013-10-30 2017-06-11 Sk化學公司 多價肺炎球菌多醣－蛋白質共軛物組成物
CN110859957B (zh) * 2014-01-21 2024-04-12 辉瑞公司 包含缀合荚膜糖抗原的免疫原性组合物及其用途
BR112016015835B1 (pt) * 2014-01-21 2023-12-26 Pfizer Inc Processo de preparação de conjugados compreendendo polissacarídeos capsulares de streptococcus pneumoniae
PL3096786T3 (pl) 2014-01-21 2021-11-08 Pfizer Inc. Polisacharydy otoczkowe streptococcus pneumoniae i ich koniugaty
US11160855B2 (en) 2014-01-21 2021-11-02 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
ES2701169T3 (es) * 2014-02-14 2019-02-21 Pfizer Conjugados glucoproteicos inmunogénicos
CN103893751B (zh) * 2014-03-26 2016-04-20 天津康希诺生物技术有限公司 一种肺炎球菌多糖蛋白缀合疫苗及其制备方法
EA201792470A1 (ru) * 2015-06-08 2018-10-31 Серум Инститьют Оф Индия Прайват Лтд. Способы улучшения адсорбции полисахарид-белковых конъюгатов и полученная из них композиция поливалентной вакцины
US11147863B2 (en) 2015-06-23 2021-10-19 Biological E Limited Multivalent pneumococcal conjugate vaccine
KR102225282B1 (ko) * 2015-07-21 2021-03-10 화이자 인코포레이티드 접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도
KR20200038339A (ko) * 2015-09-10 2020-04-10 인벤트프라이즈 엘엘씨 다가 vlp 접합체
EP3436061A4 (fr) * 2016-03-31 2019-12-04 Liffey Biotech Limited Compositions de conjugués saccharide-polypeptide polymérisables et leurs procédés d'utilisation
AU2017293942B2 (en) * 2016-07-08 2024-08-22 Access To Advanced Health Institute West Nile virus vaccine and method of use thereof
CA3031799A1 (fr) 2016-08-05 2018-02-08 Sanofi Pasteur, Inc. Composition de conjugue polysaccharide pneumococcique multivalent-proteine
CA3031797A1 (fr) 2016-08-05 2018-02-08 Sanofi Pasteur, Inc. Composition d'un conjugue polysaccharide-proteine pneumococcique multivalent
NZ752348A (en) * 2016-09-30 2022-11-25 Biological E Ltd Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates
WO2018080213A1 (fr) * 2016-10-28 2018-05-03 주식회사 엘지화학 Composition immunogène multivalente ayant un titre d'igg augmenté, et son utilisation
CN110366428B (zh) 2016-12-30 2024-05-17 Vaxcyte公司 具有非天然氨基酸的多肽-抗原缀合物
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
EP4656208A3 (fr) 2017-01-31 2026-03-04 Merck Sharp & Dohme LLC Procédés de fabrication de conjugués polysaccharide-protéine
CN110225757A (zh) 2017-01-31 2019-09-10 默沙东公司 由肺炎链球菌血清型19f生产荚膜多糖蛋白缀合物的方法
CA3052621A1 (fr) 2017-02-03 2018-08-09 Schadeck, Eva Barbara Compositions de conjugue saccharide d'haemophilus influenzae-excipient et leurs utilisations
US11219680B2 (en) * 2017-02-24 2022-01-11 Merck Sharp & Dohme Corp. Polysaccharide-protein conjugates utilizing diphtheria toxin fragment B as a carrier
MX2019009869A (es) * 2017-02-24 2019-10-02 Merck Sharp & Dohme Formulaciones de vacunas de conjugado de neumococos.
US11400162B2 (en) 2017-02-24 2022-08-02 Merck Sharp & Dohme Llc Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein
JP7680185B2 (ja) 2017-02-24 2025-05-20 メルク・シャープ・アンド・ドーム・エルエルシー 肺炎連鎖球菌多糖－タンパク質コンジュゲートの免疫原性の増強
WO2018227177A1 (fr) * 2017-06-10 2018-12-13 Inventprise, Llc Vaccins conjugués multivalents avec des polysaccharides conjugués bivalents ou multivalents qui confèrent une immunogénicité et une avidité améliorées
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
CN110996992A (zh) * 2017-08-16 2020-04-10 默沙东公司 肺炎球菌缀合物疫苗制剂
MX2020002558A (es) * 2017-09-07 2020-07-13 Merck Sharp & Dohme Procesos para la formulacion de polisacaridos neumococicos para la conjugacion a una proteina transportadora.
US11524076B2 (en) 2017-09-07 2022-12-13 Merck Sharp & Dohme Llc Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
CN111093650B (zh) * 2017-09-07 2024-03-01 默沙东有限责任公司 肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
MX394768B (es) * 2017-09-07 2025-03-21 Merck Sharp & Dohme Llc Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina.
MX394767B (es) 2017-09-07 2025-03-24 Merck Sharp & Dohme Llc Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora.
WO2019050814A1 (fr) * 2017-09-07 2019-03-14 Merck Sharp & Dohme Corp. Polysaccharides antipneumococciques et leur utilisation dans des conjugués immunogènes polysaccharide-protéine porteuse
WO2019070994A1 (fr) 2017-10-04 2019-04-11 Liffey Biotech Limited Compositions de conjugués saccharide-polypeptide et leurs procédés d'utilisation
ES3058336T3 (es) 2017-12-06 2026-03-10 Merck Sharp & Dohme Llc Composiciones que comprenden conjugados polisacárido-proteína de Streptococcus pneumoniae y métodos de uso de los mismos
BR112020014978A2 (pt) * 2018-02-05 2020-12-22 Sanofi Pasteur, Inc. Composição de conjugado polissacarídeo-proteína pneumocócico multivalente
EP3749357A4 (fr) 2018-02-05 2022-04-20 Sanofi Pasteur, Inc. Composition de conjugués polysaccharide-protéine pneumococcique multivalents
US11951162B2 (en) 2018-04-18 2024-04-09 Sk Bioscience Co., Ltd. Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereof
EP3787673A4 (fr) * 2018-04-30 2022-04-27 Merck Sharp & Dohme Corp. Procédés de production de conjugués protéine porteuse-polysaccharide capsulaire de streptococcus pneumoniae
US12144855B2 (en) 2018-04-30 2024-11-19 Merck Sharp & Dohme Llc Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates from lyospheres
EP3788143B1 (fr) 2018-04-30 2023-06-28 Merck Sharp & Dohme LLC Procédés pour fournir une solution homogène de toxine diphtérique mutante lyophilisée dans du diméthylsulfoxyde
WO2019220304A1 (fr) * 2018-05-14 2019-11-21 Tergene Biotech Pvt. Ltd. Vaccin conjugué de polysaccharide pneumococcique 15-valent
US11389519B2 (en) 2018-06-11 2022-07-19 Inventprise, Llc Virus-like particle conjugates
WO2020009462A1 (fr) * 2018-07-06 2020-01-09 주식회사 유바이오로직스 Composition immunogène multivalente comprenant des conjugués polysaccharide-protéine et vaccin la comprenant pour prévenir une maladie provoquée par streptococcus pneumoniae
EP3824019A1 (fr) * 2018-07-19 2021-05-26 GlaxoSmithKline Biologicals SA Procédés de préparation de polysaccharides séchés
CN112969474A (zh) * 2018-09-12 2021-06-15 艾芬尼维克斯公司 多价肺炎球菌疫苗
IL284349B2 (en) 2018-10-12 2025-06-01 Biological E Ltd Multivalent pneumococcal polysaccharide-protein conjugate vaccine
CR20210333A (es) 2018-12-19 2021-08-18 Merck Sharp & Dohme Composiciones que comprenden conjugados de polisacárido de streptococcus pneumoniae con proteína y sus métodos de uso
KR20220017996A (ko) * 2019-06-05 2022-02-14 머크 샤프 앤드 돔 코포레이션 면역원성 혈청형 35b 폐렴구균 폴리사카라이드-단백질 접합체 및 그를 제조하기 위한 접합 방법
BR112021024491A8 (pt) * 2019-06-05 2023-04-11 Merck Sharp & Dohme Composição imunogênica, e, método para prevenir, tratar ou melhorar uma infecção, doença ou condição
MY207971A (en) * 2019-07-18 2025-03-31 Celltrion Inc Immunogenic composition comprising multivalent streptococcus pneumoniae polysaccharide-protein conjugates
PH12022550110A1 (en) 2019-07-31 2022-12-12 Sk Bioscience Co Ltd Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
WO2021255690A2 (fr) 2020-06-19 2021-12-23 Pfizer Inc. Compositions immunogènes contre clostridioides (clostridium) difficile et méthodes associées
WO2022035816A1 (fr) 2020-08-10 2022-02-17 Inventprise, Llc Vaccins glycoconjugués pneumococciques multivalents contenant un sérotype 24f émergent
KR20220102871A (ko) * 2021-01-14 2022-07-21 (주)셀트리온 다가 폐렴구균 다당류-단백질 접합체를 포함하는 면역원성 조성물
TW202245835A (zh) 2021-02-04 2022-12-01 美商默沙東有限責任公司 用於肺炎球菌結合物疫苗之奈米乳化液佐劑組合物
CN121532194A (zh) 2023-05-18 2026-02-13 默沙东有限责任公司 用于肺炎球菌疫苗的化合物及佐剂制剂
WO2025174398A1 (fr) 2024-02-14 2025-08-21 Merck Sharp & Dohme Llc Vaccins pneumococciques conjugués 26-valents et leurs méthodes d'utilisation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2059693C (fr) 1991-01-28 2003-08-19 Peter J. Kniskern Antigenes polysaccharides de streptococcus pneumoniae
CZ20024224A3 (cs) * 2000-06-29 2003-05-14 Glaxosmithkline Biologicals S. A. Farmaceutický prostředek
GB0118249D0 (en) * 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
CN1993141A (zh) * 2004-06-04 2007-07-04 法麦克萨有限公司 诱导针对肺炎链球菌多糖的免疫应答
CN1660881A (zh) * 2005-01-12 2005-08-31 北京万赛生物医药技术发展有限公司 新型的免疫刺激分子及其制备方法
EP3311836A1 (fr) * 2005-04-08 2018-04-25 Wyeth LLC Composition conjuguée polysaccharide-protéine pneumococcique polyvalente
PE20110072A1 (es) * 2005-06-27 2011-02-04 Glaxosmithkline Biolog Sa Composicion inmunogenica
WO2007053781A2 (fr) * 2005-11-01 2007-05-10 Novartis Ag Compositions comprenant des antigenes adsorbes par du phosphate de calcium
KR101515078B1 (ko) * 2005-12-22 2015-04-24 글락소스미스클라인 바이오로지칼즈 에스.에이. 백신
EP1940462A2 (fr) * 2005-12-23 2008-07-09 GlaxoSmithKline Biologicals S.A. Vaccins conjugués
WO2007127668A2 (fr) * 2006-04-26 2007-11-08 Wyeth Nouveaux procedes de revetement d'un contenant empechant la precipitation de formulations de conjugues de polysaccharide-proteine
CN101663327B (zh) 2007-03-23 2014-05-07 惠氏公司 产生肺炎链球菌(streptococcus pneumoniae)荚膜多糖的缩短的纯化方法
CA2690708A1 (fr) * 2007-06-26 2008-12-31 Glaxosmithkline Biologicals S.A. Vaccin
CN101590224A (zh) 2009-06-30 2009-12-02 广州精达医学科技有限公司 高效14价肺炎球菌结合疫苗

Also Published As

Publication number Publication date
MY159984A (en) 2017-02-15
US20110195086A1 (en) 2011-08-11
KR101538535B1 (ko) 2015-07-22
SG183199A1 (en) 2012-09-27
BR112012019757A2 (pt) 2016-05-10
EP2533805A4 (fr) 2013-08-28
CN102858365A (zh) 2013-01-02
TW201136603A (en) 2011-11-01
ZA201205737B (en) 2013-04-24
BR112012019757B8 (pt) 2023-04-25
UA106115C2 (uk) 2014-07-25
RU2012138368A (ru) 2014-03-20
BR112012019757B1 (pt) 2020-11-17
KR20120114345A (ko) 2012-10-16
CA2788680A1 (fr) 2011-08-18
US8192746B2 (en) 2012-06-05
NZ601711A (en) 2014-03-28
JP2013518891A (ja) 2013-05-23
CA2788680C (fr) 2014-12-16
WO2011100151A1 (fr) 2011-08-18
MA34051B1 (fr) 2013-03-05
AU2011216095B2 (en) 2013-07-18
IL221283A0 (en) 2012-10-31
JP2014012720A (ja) 2014-01-23
TN2012000377A1 (en) 2014-01-30
EP2533805A1 (fr) 2012-12-19
AR116043A2 (es) 2021-03-25
SG10201500350PA (en) 2015-03-30
US20120301502A1 (en) 2012-11-29
AU2011216095A1 (en) 2012-08-09
AR080122A1 (es) 2012-03-14
PE20121698A1 (es) 2012-12-11
CL2012002195A1 (es) 2012-11-30
PH12012501559A1 (en) 2012-10-22
MX2012009206A (es) 2012-08-23

Similar Documents

Publication Publication Date Title
AR116043A2 (es) Composición de vacuna conjugada de polisacárido-proteína neumocócica 15-valente
PH12015501270A1 (en) Multivalent pneumococcal polysaccharide-protein conjugate composition
PH12015501269A1 (en) Multivalent pneumococcal polysaccharide-protein conjugate composition
PH12014502843A1 (en) Polyvalent pneumococcal polysaccharide-protein conjugate composition
AR084158A1 (es) Formulaciones que mitigan la agregacion inducida por agitacion de composiciones inmunogenicas
BRPI0607025B8 (pt) composição imunogênica 13-valente, e uso de 13 conjugados de polissacarídeo-proteína distintos
MX2009013949A (es) Vacuna que comprende conjugados de polisacárido capsular de streptococcus pneumoniae.
MX2009006705A (es) Composicion conjugada polisacarido-proteina neumococica multivalente.
MY150719A (en) Pneumococcal polysaccharide conjugate vaccine
BRPI0721136A8 (pt) conjugado imunogênico, polissacarídeos de streptococcus pneumoniae sorotipo 1, composição imunogênica multivalente e seus métodos de produção
TH171459A (th) องค์ประกอบมัลติวาเลนท์ นิวโมคอกคัสโพลีแซคคาไรด์-โปรตีน คอนจูเกต
TH128171A (th) องค์ประกอบวัคซีนคอนจูเกต 15-วาเลนท์ นิวโมคอคคอล โพลีแซคคาไรด์-โปรตีน